But that average hides important variation
Foundayo (orforglipron), a newer GLP-1 option, offers flexibility with no dietary restrictions
In subjects with T2DM, weekly administration of tirzepatide at doses of 5 mg, 10 mg, or 15 mg was associated with greater weight loss compared to placebo ( 6.3 kg, 8.4 kg, and 9.4 kg, respectively), and 1.7 kg, 4.8 kg, and 7.2 kg greater weight loss compared to selective GLP-1 receptor agonists, demonstrating a dose-dependent effect sustained for up to 2 years [48]
Individual results vary, and outcomes on compounded GLP-1 preparations may differ from outcomes documented in clinical trials using brand-name FDA-approved formulations
Inclusion/exclusion criteria, geography, and recruitment status vary
I reviewed the latest research and spoke with four experts to get a clearer picture of what GLP-1 supplements really are and whether they're worth your time (or money)